Arkema, FR0010313833

Arkema stock weakens as employee share issue and technical break shape sentiment

Published on 09/11/2026 at 20:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Arkema stock trades around the mid EUR 50s on Euronext Paris after breaking support near EUR 58 on September 11, 2026. The company’s tenth employee share issue at EUR 45.06 per share adds a dilution angle that investors must weigh against recent price moves.

Beleuchtete Chemieanlage bei Nacht mit Dampf, Tanks und Rohrleitungen im Industriegebiet
Fotorealistische Chemieanlage bei Dämmerung symbolisiert Arkema S.A. FR0010313833 und industrielle Spezialchemie-Produktion in Frankreich sehr deutlich, Illustration mit AI erstellt.

Arkema stock (ISIN FR0010313833) is trading in the mid EUR 50s on Euronext Paris as of September 11, 2026, after sliding below a key support level near EUR 58 and extending a month-long decline of about 8 percent.

Employee share issue sets fresh valuation reference

For Arkema, the most immediate corporate catalyst is its tenth capital increase reserved for current and former employees, with subscription terms anchored to recent market prices. As Ad-hoc-news summarized on September 11, 2026, the subscription price for the new employee share plan was set at EUR 45.06 per share, equal to 75 percent of the EUR 60.08 average of Arkema share opening prices over the twenty trading days preceding September 9, 2026, while the subscription period will run from September 14, 2026 to September 28, 2026.

The same coverage notes that the maximum number of shares to be issued under the operation is 1.35 million, highlighting both the importance of employee participation and the potential dilution for existing shareholders if the offer is fully taken up.Ad-hoc-news For investors, the EUR 45.06 subscription level stands out as a reference point roughly 25 percent below the EUR 60.08 average opening price used to calculate it.

Recent price action and technical picture

The employee share terms come against a backdrop of weakening share performance. According to Ideal-investisseur on September 11, 2026, Arkema stock was losing about 2.4 percent during the session to EUR 56.90, after closing the previous day at EUR 58.30, and trading around EUR 56.70 later in the day, corresponding to an intraday decline of roughly 2.7 percent.

The same analysis points out that the shares have broken down through a support level identified at EUR 58.05 during the session and failed to recover it, reinforcing a degraded short-term dynamic.Ideal-investisseur Over the week, the stock is down about 4.5 percent, and over one month the decline reaches 8 percent, illustrating how the current mid EUR 50s level compares with price territory around EUR 60 that prevailed only weeks earlier.

From a trend perspective, Ideal-investisseur notes that Arkema shares are trading below their 20-day moving average at EUR 59.61, below the 50-day moving average at EUR 58.38 and below the 200-day moving average at EUR 57.28 on September 11, 2026, suggesting that the stock has slipped under several technical reference lines simultaneously.Ideal-investisseur The same source highlights a next resistance level at EUR 62.35, implying upside of close to 10 percent from the current price region if the shares were to retest that zone; however, an RSI around 44, slightly below neutral, is said not to confirm pronounced selling exhaustion, leaving some downward pressure in place in the near term.

Analyst consensus and earnings context

Alongside the Euronext listing, Arkema is also traded in the United States via the OTCMKTS ticker ARKAY, which provides additional insight into how international investors view the stock. As MarketBeat reported on September 11, 2026, Arkema SA has been assigned a consensus recommendation of Hold from eight ratings firms covering the company, with one analyst rating the shares Sell, six rating them Hold and one rating them Buy.

The same MarketBeat overview indicates that Arkema shares opened at USD 68.03 on the OTC market on the referenced trading day, with a 12-month low of USD 56.28 and a 12-month high of USD 79.36, and a market capitalization around USD 5.17 billion based on those levels.MarketBeat In that context, equities analysts as a group are cited as forecasting earnings per share of 3.68 dollars for the current year, implying expectations that Arkema will continue to generate solid profitability despite softer share performance.

On the earnings side, a separate MarketBeat alert discussing Arkema’s recent quarterly performance notes that the company reported earnings per share of USD 1.98 for the latest quarter, beating the consensus estimate of USD 1.86 by USD 0.12.MarketBeat While the detailed reporting period is not fully spelled out in the alert snippet, the emphasis on a positive EPS surprise versus consensus underlines that, at least recently, Arkema has been able to deliver results modestly ahead of analyst expectations.

Stock closes in the mid EUR 50s on Euronext Paris

Taking the Euronext Paris quote as the primary reference, Arkema stock most recently closed at EUR 58.30 on the previous trading day and was quoted around EUR 56.70 during the session on September 11, 2026, marking a day-on-day decline in the low single-digit percent range and leaving the shares roughly 8 percent below their level one month earlier.Ideal-investisseur For investors following Arkema stock, the combination of the employee share issue priced at EUR 45.06, the technical break below EUR 58 support and the consensus Hold stance among analysts frames a picture of a specialty materials group navigating near-term pressure while still being expected to generate full-year earnings around the 3.68 dollars per share mark.

Arkema stock key data

  • Company: Arkema SA
  • ISIN: FR0010313833
  • Ticker: AKE
  • Trading venue: Euronext Paris
  • Price (as of September 11, 2026): 56.70 EUR
  • Market capitalization: 5,170,000,000 USD (as of September 11, 2026)
  • Sector / Industry: Chemicals / Specialty Materials
  • Index membership: CAC Next 20, SBF 120

More news and analyses on Arkema stock

Disclaimer...

en | FR0010313833 | ARKEMA | boerse | 70088936 | bgmi